Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHED Polymerization for Pulp Regeneration
NCT05728346Not yet recruiting
- Sponsor
- Fifth Affiliated Hospital of Guangzhou Medical University
- Start
- Sep 2023
- Primary completion
- Jun 2026
- Modality
- Stem Cell Therapies
01
Overview
Open-label, single-arm trial of SHED in pulp necrosis, sponsored by Fifth Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Assessment of pulp vitality at 24 months. Planned start Sep 2023; status: not yet recruiting.
02
Drugs
SHED
03
Conditions
pulp necrosis
Beyond the preview
Go deeper on NCT05728346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05728346.